Business Segments (Tables)

3 Months Ended

Mar. 31, 2024

Business Segments [Abstract]

Schedule of Business Segment

Summarized below is information about the Company’s operations for the three months ended March 31, 2024 and 2023 by business segment:

	Revenues				Losses
	2024		2023		2024			2023
FOXO Labs	$	4	$	7	$	(154	)	$	(290	)
FOXO Life		3		6		(5	)		(647	)
		7		13		(159	)		(937	)
Corporate and other (a)		-		-		(1,044	)		(6,477	)
Interest expense		-		-		(301	)		(225	)
Total	$	7	$	13	$	(1,504	)	$	(7,639	)

(a) For the three months ended March 31, 2024, Corporate and other includes stock-based compensation, including amortization of consulting fees paid in stock, of $144 and depreciation and amortization expense of $260. For the three months ended March 31, 2023, Corporate and other includes stock-based compensation, including consulting agreement expense, of $2,626 and depreciation and amortization expense of $929.